Characterization of BrMYB2 shows reduced flavonoid production in Nicotiana tabacum, suggesting targets for enhancement.
Flavonoids play essential roles in plant growth and development. However, their natural abundance is often low, limiting their large-scale commercial utilization. Understanding the molecular mechanisms underlying flavonoid biosynthesis is therefore critical to enhancing their production. Here, we isolated and functionally characterized BrMYB2, an R2R3-MYB transcriptional repressor from Boesenbergia rotunda. Sequence analysis revealed that BrMYB2 encodes a 219-amino acid protein with conserved subgroup 4 MYB domains, showing 92.8% similarity to a MYB-related protein from Zingiber officinale. To our knowledge, this is the first report of an R2R3-MYB repressor identified in B. rotunda. Heterologous expression of BrMYB2 in Nicotiana tabacum via Agrobacterium-mediated transformation led to the significant down-regulation of four key flavonoid biosynthetic genes (PAL, 4CL, CHI and DFR). Correspondingly, the accumulation of several targeted flavonoids, including p-coumaric acid, cinnamic acid, pinostrobin, and anthocyanin, was markedly reduced. These findings provide new insights into the transcriptional regulation of flavonoid metabolism in B. rotunda and establish a foundation for metabolic engineering strategies to enhance flavonoid production for pharmaceutical and agricultural applications.
No takes yet. Share an insight, caveat, or question.
Caliskan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: